Antibiotic Synergism of Enterococci
- 1 August 1970
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 126 (2) , 255-259
- https://doi.org/10.1001/archinte.1970.00310080061006
Abstract
Not all enterococci show synergism between penicillin and streptomycin or kanamycin, but most patients receive combined therapy empirically since tests for synergism are difficult to perform. Enterococci showing synergism are considered "resistant" to streptomycin and kanamycin, but usually have not been tested with concentrations higher than 100μ/ml. We had found that strains not showing synergism are actually highly resistant to these antibiotics, in contrast to strains that do show synergism. Of 30 strains where synergism occurred between penicillin G potassium and streptomycin sulfate when killing curves were performed, 27 were inhibited by 250μg/ml. Seventeen strains not showing synergism required 6,000μg/ml or more for inhibition and 11 grew in 50,000μg/ml Forty-four strains showing synergism between penicillin and kanamycin sulfate were inhibited by 250μg/ml or less of kanamycin sulfate, and 5 strains not showing synergism had minimal inhibitory concentrations of 25,000μg/ml or higher.This publication has 6 references indexed in Scilit:
- Vancomycin therapy for enterococcal and Streptococcus viridans endocarditis. Successful treatment of six patientsArchives of internal medicine (1960), 1968
- Ampicillin in the Treatment of Enterococcal EndocarditisAnnals of Internal Medicine, 1966
- Penicillin-Streptomycin Treatment of Enterococcal EndocarditisNew England Journal of Medicine, 1966
- Infective Endocarditis in the Antibiotic EraNew England Journal of Medicine, 1966
- Penicillin versus Combined TreatmentNew England Journal of Medicine, 1965
- Antibiotic Therapy of Bacterial EndocarditisCirculation, 1954